Abnousi Freddy, Yong Celina Mei, Fearon William, Banerjee Dipanjan
Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA, 94305, USA,
Curr Cardiol Rep. 2015 Jun;17(6):40. doi: 10.1007/s11886-015-0594-8.
Temporary percutaneous mechanical circulatory support (MCS) devices were introduced in the 1960s and have developed into a diverse portfolio of options currently available for left, right, and biventricular support. Patients undergoing high-risk percutaneous coronary interventions (PCI), patients with acute myocardial infarction (AMI), and patients with cardiogenic shock in particular may benefit from these options. In this review, we will discuss the currently available devices and the evidence supporting their use in cardiogenic shock.
临时经皮机械循环支持（MCS）设备于20世纪60年代问世，目前已发展成为一系列多样化的选择，可用于左心室、右心室和双心室支持。接受高风险经皮冠状动脉介入治疗（PCI）的患者、急性心肌梗死（AMI）患者，尤其是心源性休克患者可能会从这些选择中获益。在本综述中，我们将讨论目前可用的设备以及支持其在心源性休克中应用的证据。
